Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $24.5M | $23.1M | $13.8M | $64.5M | $117.6M | $206.1M | $139.9M | $97.2M | $21.2M | $60.5M | ($77.5M) | $86.4M | $46.5M | $95.0M | $216.9M | $194.1M | $283.6M | $182.2M | $126.1M | $124.5M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Amedisys, Inc.'s last 12-month Free Cash Flow is $203.7M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Amedisys, Inc.'s Free Cash Flow growth was 93.8%. The average annual Free Cash Flow growth rates for Amedisys, Inc. have been (15.0%) over the past three years, 2.1% over the past five years.
Over the last year, Amedisys, Inc.'s Free Cash Flow growth was 93.8%, which is higher than industry growth of 1.8%. It indicates that Amedisys, Inc.'s Free Cash Flow growth is Good.